Inventor · disambiguated record
Mark Jon Olsen
Also filed as: OLSEN MARK · OLSEN MARK J · OLSEN MARK JON
9 granted patents·11 pending applications·2 citations·filing 2001–2022
79Inventor score
Top patents by PatentIndex Score
20 records- 0182US9771356B2Inhibitors of beta-hydroxylase for treatment of cancerRHODE ISLAND HOSPITAL·Filed 2013·Granted Sep 26, 2017·2 cites·19 claims
- 0279US2022251076A1Inhibitors of Beta-Hydoxylase for Treatment of CancerUNIV MIDWESTERN·Filed 2022·Application pending·0 cites
- 0373US2022162341A1Methods of using monoclonal antibodies targeting epitopes of asphUNIV MIDWESTERN·Filed 2022·Application pending·0 cites
- 0471US2020361925A1Inhibitors of beta-hydroxylase for treatment of cancerRHODE ISLAND HOSPITAL·Filed 2020·Application pending·0 cites
- 0571US2021032233A1Inhibitors of Beta-Hydroxylase for Treatment of CancerUNIV MIDWESTERN·Filed 2020·Application pending·0 cites
- 0670US10787445B2Inhibitors of beta-hydroxylase for treatment of cancerUNIV MIDWESTERN·Filed 2019·Granted Sep 29, 2020·0 cites·13 claims
- 0768US11236178B2Methods of using monoclonal antibodies targeting epitopes of ASPHUNIV MIDWESTERN·Filed 2020·Granted Feb 1, 2022·0 cites·13 claims
- 0867US10961320B2Monoclonal antibodies targeting epitopes of ASPHUNIV MIDWESTERN·Filed 2019·Granted Mar 30, 2021·0 cites·13 claims
- 0967US10351555B2Inhibitors of β-hydroxylase for treatment of cancerUNIV MIDWESTERN·Filed 2018·Granted Jul 16, 2019·0 cites·20 claims
- 1064US10710995B2Inhibitors of β-hydroxylase for treatment of cancerRHODE ISLAND HOSPITAL·Filed 2017·Granted Jul 14, 2020·0 cites·13 claims
- 1164US10106532B2Inhibitors of beta-hydroxylase for treatment of cancerUNIV MIDWESTERN·Filed 2017·Granted Oct 23, 2018·0 cites·11 claims
- 1259US2007009972A1Epidermal growth factor receptor polypeptides and antibodiesCHAO GINGER·Filed 2006·Application pending·0 cites
- 1357US2007258954A1Directed evolution of enzymes and antibodiesIVERSON BRENT·Filed 2005·Application pending·0 cites
- 1455US11897857B2Isotopically-stabilized tetronimide compoundsUNIV MIDWESTERN·Filed 2020·Granted Feb 13, 2024·0 cites·8 claims
- 1555US2009137784A1Epidermal Growth Factor Receptor Polypeptides and AntibodiesCHAO GINGER·Filed 2009·Application pending·0 cites
- 1652US10961211B2Isotopically-stabilized tetronimide compoundsUNIV MIDWESTERN·Filed 2020·Granted Mar 30, 2021·0 cites·28 claims
- 1752US2023096103A1Berberine compounds, berberine compositions, and methods for administration thereofDIGNITY HEALTH·Filed 2020·Application pending·0 cites
- 1850US2003036092A1Directed evolution of enzymes and antibodiesUNIV TEXAS·Filed 2001·Application pending·0 cites
- 1950US2021052561A1Targeting aspartate beta-hydroxylase suppresses tumor malignancy and metastasisRHODE ISLAND HOSPITAL·Filed 2020·Application pending·0 cites
- 2050US2004072740A1Directed evolution of enzymes and antibodiesUNIV TEXAS·Filed 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Jon Olsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →